9783030393281 - behavioral clinical trials for chronic diseases: scientific foundations von powell, lynda h.; freedland, kenneth e.; kaufmann, peter g. (5 Ergebnisse)
- Hardcover
Anbieter: Books From California, Simi Valley, USABooks From California
Verkäufer/-in kontaktierenVerkäufer/-in mit 4 SternenZustand: Gebraucht - Befriedigend
EUR 61,01
EUR 4,33 VersandVersand innerhalb von USAAnzahl: 1 verfügbar
hardcover. Zustand: Good.
- Hardcover
Anbieter: Books From California, Simi Valley, USABooks From California
Verkäufer/-in kontaktierenVerkäufer/-in mit 4 SternenZustand: Gebraucht - Gut
EUR 61,01
EUR 4,33 VersandVersand innerhalb von USAAnzahl: 4 verfügbar
hardcover. Zustand: Very Good.
- Hardcover
Anbieter: Books From California, Simi Valley, USABooks From California
Verkäufer/-in kontaktierenVerkäufer/-in mit 4 SternenZustand: Gebraucht - Sehr gut
EUR 61,01
EUR 4,33 VersandVersand innerhalb von USAAnzahl: 1 verfügbar
hardcover. Zustand: Fine.
- Hardcover
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 115,42
EUR 13,86 VersandVersand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
Zustand: New. In.
- Hardcover
Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 117,69
EUR 63,32 VersandVersand von Deutschland nach USAAnzahl: 1 verfügbar
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This is the first comprehensive guide to the design of behavioral randomized clinical trials (RCT) for chronic diseases. It includes the scientific foundations for behavioral trial methods, problems that have been encountered in past behavioral trials, adva…nces in design that have evolved, and promising trends and opportunities for the future. The value of this book lies in its potential to foster an ability to 'speak the language of medicine' through the conduct of high-quality behavioral clinical trials that match the rigor commonly seen in double-blind drug trials. It is relevant for testing any treatment aimed at improving a behavioral, social, psychosocial, environmental, or policy-level risk factor for a chronic disease including, for example, obesity, sedentary behavior, adherence to treatment, psychosocial stress, food deserts, and fragmented care. Outcomes of interest are those that are of clinical significance in the treatment of chronic diseases, including standard risk factors such as cholesterol, blood pressure, and glucose, and clinical outcomes such as hospitalizations, functional limitations, excess morbidity, quality of life, and mortality. This link between behavior and chronic disease requires innovative clinical trial methods not only from the behavioral sciences but also from medicine, epidemiology, and biostatistics. This integration does not exist in any current book, or in any training program, in either the behavioral sciences or medicine.
